March 16, 2026 · Form 4 insider transaction
Prasad Raju sold 750 shares of CRISPR Therapeutics AG at $0.00 per share, a transaction worth N/A. The trade was recorded as gift and disclosed on an SEC Form 4, filed 1 day after the transaction.
Reporting person remains subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031. Transfers of lock-up securities as a bona fide gift are permitted. No consideration was received by the reporting person in connection with such transfer.